In conclusion, TTM, a novel syncarpic acid-conjugated monoterpene, increases cytotoxicity of chemotherapeutic drugs in MDR cancer cells by decreasing P-gp expression via p38 MAPK inhibition (Figure 7). The gene discussed is PGP; the disease is cancer.